17 employees
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
2013
$84M
from 3 investors over 3 rounds
LENZ Therapeutics raised $84M on March 7, 2023
Investors: Sectoral Asset Management
LENZ Therapeutics raised $47M on June 17, 2021
Investors: RA Capital Management, L.P. and Versant Ventures